Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00202046 · ClinicalTrials.gov registry record
Predictors of Lymphedema Following Breast Cancer Surgery
A clinical trial, sponsored by HealthPartners Institute.
- Completed
- Registry status
- 188
- Enrollment target
NCT00202046: Completed study, sponsored by HealthPartners Institute.
NCT00202046 is a clinical trial that has completed, run by HealthPartners Institute. The registered enrollment target is 188 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00202046 has completed, sponsored by HealthPartners Institute.
- COMPLETED
- Registry status
- 188 participants
- Enrollment target
Study Summary
The purpose of this study evaluate which factors play a role in lymphedema development among women who have had axillary surgery for breast cancer. Potential risk factors for women who have developed lymphedema will be compared to risk factors among women who have not developed lymphedema after breast cancer surgery.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 188 participants |
| Start Date | 2003-01 |
| Est. Completion | 2008-05 |
What the finished NCT00202046 record still lists
NCT00202046 is an observational study that tracks outcomes without assigning an intervention. The registered 188 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT00202046 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00202046 about?
NCT00202046 is a clinical study titled "Predictors of Lymphedema Following Breast Cancer Surgery". The purpose of this study evaluate which factors play a role in lymphedema development among women who have had axillary surgery for breast cancer. Potential risk factors for women who have developed lymphedema will be compared to risk factors among women who have not developed lymphedema after brea...
What is the current status of trial NCT00202046?
This trial is currently completed. The enrollment target is 188 participants. The study started on 2003-01. Estimated completion is 2008-05.
Who is sponsoring clinical trial NCT00202046?
This trial is sponsored by HealthPartners Institute, which has 146 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03422198 · 188 participants · Phase 3
Short Course Vaginal Cuff Brachytherapy in Treating Participants With Stage I-II Endometrial Cancer
- NCT04469790 · 188 participants · NA
Effects of Multi-day Interruptions in Sitting on Type 2 Diabetes-relevant Outcomes in Children
- NCT04671667 · 188 participants · Phase 2
Testing What Happens When an Immunotherapy Drug (Pembrolizumab) is Given by Itself Compared to the Usual Treatment of Chemotherapy With Radiation After Surgery for Recurrent Head and Neck Squamous Cell Carcinoma
- NCT04853251 · 188 participants · Phase 4
A Study Assessing Corneal Endothelial Cells in Participants With Neovascular Age-related Macular Degeneration (nAMD) Treated With the Port Delivery System With Ranibizumab (PDS)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia